Perspectives on Life Sciences
313 total results. Page 1 of 13.
Sailesh Patel will present at the 6th World Legal Tech Summit on September 8, 2023.
Artificial intelligence promises to transform the way we live and work and its impact will undoubtedly stretch to every business sector across the globe. This next generation of technology brings exciting possibilities and unknown legal risks.
Artificial intelligence (AI) is rapidly transforming the life sciences industry, with significant advancements in various areas. These innovations bring new legal challenges related to intellectual property, data protection, regulatory compliance, and ethical considerations.
ArentFox Schiff is pleased to announce that the firm and three partners have been shortlisted for the annual LMG Life Sciences Americas Awards.
Health Care Partner Hillary Stemple will present at the American Health Law Association’s (AHLA) Annual Meeting on June 26, 2023.
ArentFox Schiff is pleased to announce that 93 attorneys and 21 practices have been ranked by The Legal 500 United States 2023 guide, a nationwide analysis of law firms that provide cutting-edge and innovative advice.
AgTech Industry Group Co-Leaders Karen Carr and Alexander Spiegler will speak at the International Bar Association’s 9th Annual IBA World Life Sciences Conference.
For decades, the Securities and Exchange Commission (SEC) and criminal prosecutors have pursued claims for insider trading in securities by persons who learn material nonpublic information about clinical drug trials.
Partner Andy Sawula and Associate Sam Rasche discuss how to respond to EPA Information Requests.
ArentFox Schiff advised Kindeva Drug Delivery in its combination with Meridian Medical Technologies.
ArentFox Schiff represented NorthView Acquisition Corp., a publicly traded special purpose acquisition company, in its merger with Profusa, Inc., a digital health company.
We represented NextPlat Corp., a global e-commerce platform company, in its strategic investments in Progressive Care Inc., a personalized healthcare services and technology company.
ArentFox Schiff advised GBS Inc. (Nasdaq: GBS) on its acquisition of Intelligent Fingerprinting Limited, including its proprietary drugs of abuse screening technology.
Byron Dorgan*, Doug Jones*, Philip S. English*, Dan H. Renberg, Jon S. Bouker, Craig Engle, David P. Grosso, Cissy Jackson, Oliver Spurgeon III*, Amy Antoniolli, Stephen P. Hanson, Laura E. Doyle*, Jeri Freirich*, Daniel Sjostedt*
Americans woke up on Wednesday, November 9, immediately realizing something was different. On their televisions and other devices, they only saw commercials for products, vacation spots, and reality shows.
ArentFox Schiff is pleased to announce that five attorneys have been ranked by LMG Life Sciences, which recognizes the work of outstanding individuals in the life sciences sector.
We represented Boustead Securities, LLC as the sole underwriter in Know Labs, Inc.’s $8.28 million public offering of common stock.
ArentFox Schiff secured an important victory for Azurity Pharmaceuticals, Inc. when the US Court of Appeals for the First Circuit found that the Food, Drug, and Cosmetic Act permits a pharmaceutical company to pursue false advertising claims against a compounding pharmacy, Edge Pharma, LLC.
The Metaverse stands to disrupt nearly every industry – fashion, media and entertainment, real estate, sports, the list goes on – presenting immense possibilities and potential risks. We have created the ArentFox Schiff Industry Guide to the Metaverse to answer questions and anticipate concerns.
ArentFox Schiff is pleased to announce that the firm and two partners have been shortlisted for the annual LMG Life Sciences Americas Awards.
The life sciences and pharmaceutical industry is investigating potential applications in the Metaverse to reduce costs, increase efficiency, and develop novel functionalities.
“Metaverse” is no longer a mere buzzword. Many industries are discovering and developing applications for the Metaverse, and the pharma and biotech industry is no different.
ArentFox Schiff Intellectual Property Partner Alex Spiegler will present at the International Bar Association (IBA) 8th Annual World Life Sciences Conference.
Directors owe fiduciary duties to the company. To make informed decisions and satisfy those fiduciary duties, directors generally have broad access to the company’s books and records, with a few exceptions.
ArentFox Schiff LLP represented The Benchmark Company, LLC as underwriter in Tenon Medical, Inc.’s initial public offering. The $16 million IPO closed on April 29, 2022.
Richard J. Berman, Sailesh K. Patel, Imron T. Aly, Kevin M. Nelson, Bradford C. Frese, Taniel E. Anderson
ArentFox Schiff is sponsoring the ACI Paragraph IV Disputes Conference and Rich Berman and Sal Patel will present.